Therapeutic agents targeting apolipoprotein C-III While statins effectively prevent atherosclerosis through LDL-C lowering, agents targeting ApoC-III may further suppress the residual lipid-rich plaque as well as development and progression of CAC, including severe calcification and calcified nodules
A typical NAD++ IV session lasts between 60 to 90 minutes, depending on your individual needs and treatment goals
Unlike other cognitive enhancers, our Jupiter Dihexa peptide therapy specifically targets the brains regenerative processes, making it a powerful tool for boosting memory, focus, and overall cognitive performance
These electrons react with molecular oxygen to generate superoxide and subsequently hydrogen peroxide
In addition, carnitine works to balance the levels of coenzyme A (CoA) in your mitochondria
A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer